BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33461418)

  • 1. Early academic achievement of HIV-exposed uninfected children compared to HIV-unexposed uninfected children at 5 years of age.
    Young JM; Bitnun A; Read SE; Smith ML
    Child Neuropsychol; 2021 May; 27(4):532-547. PubMed ID: 33461418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopment of HIV-exposed uninfected children compared with HIV-unexposed uninfected children during early childhood.
    Young JM; Bitnun A; Read SE; Smith ML
    Dev Psychol; 2022 Mar; 58(3):551-559. PubMed ID: 35286108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.
    Kerr SJ; Puthanakit T; Vibol U; Aurpibul L; Vonthanak S; Kosalaraksa P; Kanjanavanit S; Hansudewechakul R; Wongsawat J; Luesomboon W; Ratanadilok K; Prasitsuebsai W; Pruksakaew K; van der Lugt J; Paul R; Ananworanich J; Valcour V;
    AIDS Care; 2014; 26(11):1327-35. PubMed ID: 24878112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and health outcomes at school age in HIV-exposed, uninfected Zambian children: follow-up of two cohorts studied in infancy.
    Nicholson L; Chisenga M; Siame J; Kasonka L; Filteau S
    BMC Pediatr; 2015 Jun; 15():66. PubMed ID: 26048411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In utero antiretroviral exposure and sociodemographic characteristics on neurodevelopment of HIV-exposed uninfected children versus HIV-unexposed uninfected healthy children in Malawi.
    Zhang X; Wang L; Han J; Xie L; Wu N; Nyirenda R; Shumba K; Simwanza W; Kulyk O; Chilapondwa V; Li X
    Int J Gynaecol Obstet; 2021 Jun; 153(3):424-437. PubMed ID: 33270235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.
    Chaudhury S; Williams PL; Mayondi GK; Leidner J; Holding P; Tepper V; Nichols S; Magetse J; Sakoi M; Moabi K; Makhema J; Mdluli C; Jibril H; Seage GR; Kammerer B; Lockman S
    Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28912368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.
    Nozyce ML; Huo Y; Williams PL; Kapetanovic S; Hazra R; Nichols S; Hunter S; Smith R; Seage GR; Sirois PA;
    Pediatr Infect Dis J; 2014 Nov; 33(11):1128-33. PubMed ID: 25361407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental outcomes in young children born to HIV-positive mothers in rural Yunnan, China.
    Wu J; Li J; Li Y; Loo KK; Yang H; Wang Q; Duan R; Xiao X; Song X; Yang S; Sun L
    Pediatr Int; 2018 Jul; 60(7):618-625. PubMed ID: 29663621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
    Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
    AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal development of cognitive, visuomotor and adaptive behavior skills in HIV uninfected children, aged 3-5 years of age, exposed pre- and perinatally to anti-retroviral medications.
    Smith ML; Puka K; Sehra R; Read SE; Bitnun A
    AIDS Care; 2017 Oct; 29(10):1302-1308. PubMed ID: 28482682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower academic performance among children with perinatal HIV exposure in Botswana.
    Powis KM; Lebanna L; Schenkel S; Masasa G; Kgole SW; Ngwaca M; Kgathi C; Williams PL; Slogrove AL; Shapiro RL; Lockman S; Mmalane MO; Makhema JM; Jao J; Cassidy AR
    J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26165. PubMed ID: 37909233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of HIV-exposed uninfected, compared with HIV-unexposed, Zambian children: a longitudinal analysis from infancy to school age.
    Rosala-Hallas A; Bartlett JW; Filteau S
    BMC Pediatr; 2017 Mar; 17(1):80. PubMed ID: 28302082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance of cognitive and academic achievement outcomes in youth with perinatal HIV exposure.
    Garvie PA; Zeldow B; Malee K; Nichols SL; Smith RA; Wilkins ML; Williams PL;
    Pediatr Infect Dis J; 2014 Sep; 33(9):e232-8. PubMed ID: 25361033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
    Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
    AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study.
    Wedderburn CJ; Yeung S; Rehman AM; Stadler JAM; Nhapi RT; Barnett W; Myer L; Gibb DM; Zar HJ; Stein DJ; Donald KA
    Lancet Child Adolesc Health; 2019 Nov; 3(11):803-813. PubMed ID: 31515160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cohort profile: longitudinal and population comparison of children who are HIV-exposed uninfected and children who are HIV unexposed in Kenya (HOPE study).
    Njuguna IN; King'e M; Moraa H; Kumar M; Benki-Nugent S; Wagner AD; McGrath CJ; Dorsey S; Ndegwa S; Onyango A; Wamalwa D; John-Stewart G
    BMJ Open; 2024 Jun; 14(6):e081975. PubMed ID: 38844397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana.
    Cassidy AR; Williams PL; Leidner J; Mayondi G; Ajibola G; Makhema J; Holding PA; Powis KM; Batlang O; Petlo C; Shapiro R; Kammerer B; Lockman S
    Pediatr Infect Dis J; 2019 Aug; 38(8):828-834. PubMed ID: 30985518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Vitamin D is Differentially Associated with Socioemotional Adjustment in Early School-Aged Ugandan Children According to Perinatal HIV Status and In Utero/Peripartum Antiretroviral Exposure History.
    Yakah W; Fenton JI; Sikorskii A; Zalwango SK; Tuke R; Musoke P; Boivin MJ; Giordani B; Ezeamama AE
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31336843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children.
    Birungi N; Fadnes LT; Engebretsen IMS; Lie SA; Tumwine JK; Åstrøm AN;
    BMC Public Health; 2020 Mar; 20(1):423. PubMed ID: 32228542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.